GCAN
TRAFALGAR INTERNATIONAL, INC.
Key Financials
Gross Profit
$-25
0.0%
Revenue
$12630
0.0%
Net Income
$-331612
↓ 85.2%
Operating Income
$-183005
↓ 17.1%
EPS (Diluted)
$0.00
NaN%
Total Assets
$815.00
↓ 98.6%
Total Liabilities
$742464.00
↓ 17.3%
Shareholders' Equity
$-741649.00
↑ 11.7%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| 8-K | 9/21/2026 | View on SEC |
| 10-Q | 8/14/2026 | View on SEC |
| SC 14F1 | 7/31/2026 | View on SEC |
| 8-K | 7/31/2026 | View on SEC |
| SCHEDULE 13D | 7/16/2026 | View on SEC |
| 3 | 7/16/2026 | View on SEC |
| 3 | 7/16/2026 | View on SEC |
| SC 14F1 | 7/6/2026 | View on SEC |
| 8-K | 7/6/2026 | View on SEC |
| 10-Q | 5/13/2026 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | GCAN |
| Company Name | TRAFALGAR INTERNATIONAL, INC. |
| CIK | 1695473 |
| Sector | Pharmaceutical Preparations |
| Industry | Non-accelerated filer Smaller reporting company |
| Exchange | OTC |
| SIC Code | 2834 |
| SIC Description | Pharmaceutical Preparations |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | FL |
| Phone | (443) 738-4051 |